•  I
• a · A  I
• Accesibility  I
• Map  I
• Search  I
• Staff directory

• ::  Iniciar sessió :: 

The Universitat Politècnica de València (UPV) is the number one university in Spain in European Innovation Council projects. With a total of 11 funded projects, the UPV is not only the leading university in this field but also in funding, with more than six million euros allocated to its research. Furthermore, the UPV coordinates four of these projects, which underlines its key role in applied research and technology transfer and reaffirms its leadership in national university innovation.

Among the most relevant projects to have received EIC funding are initiatives such as NanoBiCar, which is working on new immunotherapy for infectious diseases; SYNFEED, which seeks to develop synthetic proteins for animal feed; and DISRUPT, the project that is developing cheaper, lighter and smaller tomographic microscopes capable of revolutionising medical diagnosis. These are just some of the 11 projects at the UPV funded by the EIC.

The mission of the EIC, within the framework of the European Union's Horizon Europe programme, is to support pioneering projects that provide solutions to major social and economic challenges. With an overall budget of over 10 billion euros, the EIC supports projects from their early research stages to the creation of innovative companies, including proof of concept and technology transfer.

UPV innovations for health and environment

The NanoBiCar project, led by Research Ramón Martínez Máñez, focuses on the development of a pioneering immunotherapy against bacterial infections, with an initial focus on tuberculosis (TB). The aim is to develop a therapy that is safe, accessible, and effective in low-resource settings, with potential for application in a variety of bacterial infections.

The SYNFEED project, led by Juan José Pascual, director of the Research Institute for Environmental Science and Technology (ICTA) at UPV, aims to transform the animal feed industry through the development of sustainable biosynthetic proteins, which would reduce dependence on imported soy and minimise environmental impact.

Another outstanding project is DISRUPT, led by the researcher Amadeu Griol, who is developing integrated tomography microscopy technology to revolutionise medical diagnosis. The resulting devices, which will be smaller and lighter than current ones, are expected to have crucial applications in telemedicine, cancer diagnosis and other areas of healthcare.

In addition, the DAM4CO2 project seeks to address one of the significant global challenges: reducing greenhouse gas emissions through membrane technology for capturing and converting CO2 into renewable fuels.

The other UPV innovations funded by EIC are CHIRALFORCE (production of drugs through the synthesis of chiral molecules), QUADRATURE (its goal is to advance the implementation of quantum computers on a large scale), BEYOND (improvement of energy efficiency in buildings and cities), PRISMA (development of tools for the early diagnosis and monitoring of diseases), SWEATPATCH (patches that allow the monitoring of health through sweat analysis), SUPERVAL (industrial waste management) and ZEUS (integration of renewable energy sources into electricity grids).